Close

CD44v6

All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.

Product List Background Anti-CD44V6 CAR-T Services Anti-CD44V6 CAR-T In Vitro Assay ServicesAnti-CD44V6 CAR-T In Vivo Assay Services

Product List

Creative Biolabs provides a wide selection of CD44V6 molecular-related items, such as CAR vector items, CAR cell items, CAR viral particles, CAR animal cells, etc. These offerings aim to support the progress of CD44V6-targeted CAR-T therapy. Please refer to the list below to find the product that you need.

Background

As a glycoprotein found on the surface of cells, CD44 plays a role in the growth, differentiation, and spread of tumors. CD44v6 is a specific variant of CD44 that is mainly expressed at high levels in solid cancers. It has been involved in the development of tumors, the invasion of tumor cells, and the spread of cancer. CD44v6 also includes exon 11 and is highly expressed in various types of malignancies, including squamous cell carcinomas in the head, neck, lung, skin, cervix, and esophagus, as well as breast, gastrointestinal, hepatocellular, and colorectal cancers, and certain subtypes of acute myeloid leukemias (AML). The effectiveness of using a CD44v6 chimeric antigen receptor (CAR) has been investigated in clinical trials for the treatment of AML, multiple myeloma, and solid cancers.

Fig.1 Schematic structure of the CD44v6-LNGFR CAR. (Stornaiuolo, et al., 2021)Fig.1 Schematic structure of the CD44v6-LNGFR CAR.1

Anti-CD44V6 CAR-T Services

Anti-CD44V6 CAR-T In Vitro Assay Services

CD44V6 CAR-T Expression Test

Creative Biolabs offers a complete series of protein products to detect the expression of anti-CD44v6 CART cells. These protein and cell products have been widely used for the expression test of anti-CD44v6 CAR-T cells.

  • Unconjugated CD44v6
  • Biotinylated CD44v6
  • Fluorescent-labeled CD44v6
  • Custom cells with CD44v6 overexpression

Fig.2 Biochemical analysis of the CD44v6 CAR expression. (Stornaiuolo, et al., 2021)Fig.2 Biochemical analysis of the CD44v6 CAR expression.1

CD44V6 CAR-T Cytokine Release Test

The production of intracellular cytokines (such as TNF-α and IFN-γ) can be assessed using flow cytometry on CAR T cells that have been cultured with various types of target cells.

Fig.3 Analysis of intracellular cytokine production of CD44v6 CAR T cells by flow cytometry. (Stornaiuolo, et al., 2021)Fig.3 Analysis of intracellular cytokine production of CD44v6 CAR T cells by flow cytometry.1

CD44V6 CAR-T In Vitro Cytotoxicity Assay

CD44v6 CAR-T exhibits only mild damage to human umbilical vein endothelial cells (HUVECs) and slight non-tumor cytotoxicity towards T lymphocytes. Creative Biolabs provides exclusive cytotoxicity testing services specifically designed for CD44v6 CAR-T cells. CD44v6-positive tumor cell lines can be used for this purpose.

Fig.4 Cytotoxic activity of the differentiated CD44v6 CAR T cells. (Stornaiuolo, et al., 2021)Fig.4 Cytotoxic activity of the differentiated CD44v6 CAR T cells. 1

CD44V6 CAR-T Cell Proliferation Test

We assure our customers that Creative Biolabs provides top-notch service for customized CAR-T cell proliferation assays.

Fig.5 Impact of spacer region of CD44v6 CART on T cells proliferation and activation. (Stornaiuolo, et al., 2021)Fig.5 Impact of spacer region of CD44v6 CART on T cells proliferation and activation.1

Anti-CD44V6 CAR-T In Vivo Assay Services

CD44V6 CAR-T Cell Therapy Animal Models

Creative Biolabs has developed a diverse selection of efficient models for in vivo evaluation, including immune-oncology animal models, syngeneic models, humanized mice models, patient-derived xenografted (PDX) models, patient-derived organoid models, and cell line-derived xenografted (CDX) models for CD44v6 CAR-T therapy.

Fig.6 In vivo antitumor activity of CD44v6 CART analyzed in THP-1 high-burden disease model. (Stornaiuolo, et al., 2021)Fig.6 In vivo antitumor activity of CD44v6 CART analyzed in THP-1 high-burden disease model.1

Efficacy Test of CD44V6 CAR-T

We have a variety of testing methods at our disposal, such as in vivo imaging, flow cytometry, histologic and pathologic analysis, and clinical observation, enabling us to assess the therapeutic effectiveness of CD44v6 CAR-T cell therapy.

Fig.7 Analysis of potent anti-tumour efficacy of CD44v6 CAR-T cells in vivo. (Tang, et al., 2022)Fig.7 Analysis of potent anti-tumor efficacy of CD44v6 CAR-T cells in vivo.2

Toxicity Evaluation of CD44V6 CAR-T

Creative Biolabs offers CAR-T cell toxicity evaluation service, leveraging our profound expertise in preclinical in vivo research, project management, and our ability to employ suitable models, design comprehensive research protocols, and conduct reliable high-quality in vivo studies.

Please feel free to get in touch with us for more information on CD44V6 CAR-related services and products.

References

  1. Stornaiuolo, Anna, et al. "Characterization and functional analysis of CD44v6. CAR T cells endowed with a new low-affinity nerve growth factor receptor-based spacer." Human Gene Therapy 32.13-14 (2021): 744-760.
  2. Tang, Ling, et al. "CD44v6 chimeric antigen receptor T cell specificity towards AML with FLT3 or DNMT3A mutations." Clinical and Translational Medicine 12.9 (2022): e1043.
  • CAR Vector Products

  • AbTCR Vector Products

  • CAR Cell Products

  • CAR Viral Particles

  • CAR-MA Vector Products

  • CAR-MA Cell Products

  • CAR mRNA

Loading...
  • Target Species:
  • Antibody Clone:
  • Antibody Host:
  • Receptor Construction:
  • Vector Type:
  • Targeting Cell Type:
  • CAR Vector Type:
CAT Product Name Target Species Antibody Clone Antibody Host Receptor Construction Vector Type Targeting Cell Type CAR Vector Type Inquiry & Datasheet
CAR-LC346 Anti-CD44v6 h(CD28-CD3ζ, LNGFR) Marked CAR, pCDCAR1 Human Human scFv-LNGFR-CD28-CD3ζ Retroviral T cell   Add to Cart   Datasheet
CAR-0720ZP13 Anti-CD44v6 (BIWA4) h(CD28-CD3ζ) CAR, pCDCAR1 Human BIWA4 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP25 Anti-CD44v6 (BBA13) h(CD28-CD3ζ) CAR, pCDCAR1 Human BBA13 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP26 Anti-CD44v6 (BBA13) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human BBA13 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP27 Anti-CD44v6 (BBA10) h(CD28-CD3ζ) CAR, pCDCAR1 Human BBA10 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP28 Anti-CD44v6 (BBA10) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human BBA10 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP29 Anti-CD44v6 (U36) h(CD28-CD3ζ) CAR, pCDCAR1 Human U36 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP30 Anti-CD44v6 (U36) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human U36 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP31 Anti-CD44v6 (BIWA 1) h(CD28-CD3ζ) CAR, pCDCAR1 Human BIWA 1 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP32 Anti-CD44v6 (BIWA 1) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human BIWA 1 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP33 Anti-CD44v6 (MA54) h(CD28-CD3ζ) CAR, pCDCAR1 Human MA54 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP34 Anti-CD44v6 (MA54) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human MA54 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP35 Anti-CD44v6 (9A4) h(CD28-CD3ζ) CAR, pCDCAR1 Human 9A4 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP36 Anti-CD44v6 (9A4) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human 9A4 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP37 Anti-CD44v6 (2F10) h(CD28-CD3ζ) CAR, pCDCAR1 Human 2F10 Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP38 Anti-CD44v6 (2F10) h(4-1BB-CD3ζ) CAR, pCDCAR1 Human 2F10 Mouse scFv-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
CAR-0720ZP39 Anti-CD44v6 (BIWA) h(CD28-CD3ζ) CAR, pCDCAR1 Human BIWA Mouse scFv-CD28-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
XS-0622-ZP3477 Anti-CD44v6 h(VHH1-VHH2-4-1BB-CD3ζ) Biepitopic CAR, pCDCAR1 VHH1-VHH2-4-1BB-CD3ζ Lentiviral vector T Cell   Add to Cart   Datasheet
XS-0822-YF185 Anti-Human CD44v6 (XW-185) h(41BB-CD3ζ) CAR IVT Plasmid, pCARIVT Human XW-185 Humanized scFv-41BB-CD3ζ In Vitro Transcription (IVT) Vector   Add to Cart   Datasheet
XS-1122-YF185 Anti-CD44v6 KIR CAR (scFv-KIR2DS2-DAP12, XW-185), pCDCAR1 Human XW-185 Humanized scFv-KIR2DS2 TM&ICD-2A-DAP12 Lentiviral vector T Cell   Add to Cart   Datasheet
Unable to find the desired product? Explore the Filter Options at the top of the list.
Key Updates
Newsletter NEWSLETTER

The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders

LEARN MORE NEWSLETTER
New Solution NEW SOLUTION

CellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.

LEARN MORE SOLUTION
NOVEL SOLUTION NOVEL TECHNOLOGY

Silence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.

LEARN MORE NOVEL TECHNOLOGY
NEW TECHNOLOGY NEW SOLUTION

Canine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.

LEARN MORE SOLUTION
Receive our latest news and insights.